Insider · CIK 0001267854

DRAKE PETER F

Reports to the SEC for 5 companies · DANBURY, CT

sec.gov

Transactions

Companies

Filings

CIK

0001267854

Forms 4 and 5

Insider transactions

43 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2019-05-09	TRVITrevi Therapeutics, Inc.C Conversion	10% Owner	CConversion	+62.5K sh	—	—	62,540
2019-05-09	TRVITrevi Therapeutics, Inc. · Series A Preferred StockC Conversion	10% Owner	CConversion	−133K sh	—	—	0
2019-05-09	TRVITrevi Therapeutics, Inc. · Series C Preferred StockC Conversion	10% Owner	CConversion	−376K sh	—	—	0
2015-07-16	NAVIDEA BIOPHARMACEUTICALS, INC.D Disposition to Issuer	Director	DDisposition to Issuer	−22K sh	$0.01	−$220	77,829
2015-03-26	NAVIDEA BIOPHARMACEUTICALS, INC.A Award	Director	AAward	+22K sh	—	—	99,839
2015-02-05	NAVIDEA BIOPHARMACEUTICALS, INC.A Award	Director	AAward	+7,606 sh	$1.89	+$14.4K	77,829
2014-11-10	NAVIDEA BIOPHARMACEUTICALS, INC.A Award	Director	AAward	+11K sh	$1.32	+$14.5K	70,223
2014-02-13	NAVIDEA BIOPHARMACEUTICALS, INC.A Award	Director	AAward	+20K sh	—	—	59,250
2013-02-21	NAVIDEA BIOPHARMACEUTICALS, INC.A Award	Director	AAward	+12.3K sh	—	—	39,250
2012-08-03	RespireRx Pharmaceuticals Inc.Options to Purchase Common StockA Award	Director	AAward	+347K sh	—	—	376,667
2012-08-03	RespireRx Pharmaceuticals Inc.Options to Purchase Common StockA Award	Director	AAward	+30K sh	—	—	30,000
2012-04-10	NAVIDEA BIOPHARMACEUTICALS, INC.A Award	Director	AAward	+17K sh	—	—	27,000
2011-09-15	NAVIDEA BIOPHARMACEUTICALS, INC.P Purchase	Director	PPurchase	+10K sh	$3.08	+$30.8K	10,000
2011-05-06	DIRECT MARKETS HOLDINGS CORP.A Award	Director	AAward	+10K sh	—	—	49,768
2011-03-01	RespireRx Pharmaceuticals Inc.Options to Purchase Common StockA Award	Director	AAward	+30K sh	—	—	30,000
2010-09-20	PENWEST PHARMACEUTICALS COU Disposition from Tender	Director	UDisposition from Tender	−100K sh	—	—	0
2010-04-01	PENWEST PHARMACEUTICALS COA Award	Director	AAward	+2,240 sh	$3.46	+$7,750.4	100,263
2010-03-03	RespireRx Pharmaceuticals Inc.Options to Purchase Common StockA Award	Director	AAward	+30K sh	—	—	30,000
2010-02-19	PENWEST PHARMACEUTICALS COA Award	Director	AAward	+100 sh	$2.50	+$250	98,023
2010-01-04	PENWEST PHARMACEUTICALS COA Award	Director	AAward	+6,000 sh	—	—	95,261
2010-01-04	PENWEST PHARMACEUTICALS COA Award	Director	AAward	+2,662 sh	$2.63	+$7,001.06	97,923
2009-10-30	DIRECT MARKETS HOLDINGS CORP.A Award	Director	AAward	+30K sh	—	—	39,768
2009-10-02	PENWEST PHARMACEUTICALS COA Award	Director	AAward	+3,286 sh	$2.13	+$6,999.18	89,261
2009-08-22	RespireRx Pharmaceuticals Inc.Options to Purchase Common StockA Award	Director	AAward	+30K sh	—	—	30,000
2009-07-01	PENWEST PHARMACEUTICALS COA Award	Director	AAward	+2,536 sh	—	—	85,975
2009-06-05	RespireRx Pharmaceuticals Inc.Options to Purchase Common StockA Award	Director	AAward	+30K sh	—	—	30,000
2009-04-13	PENWEST PHARMACEUTICALS COA Award	Director	AAward	+12K sh	—	—	83,439
2009-04-01	PENWEST PHARMACEUTICALS COA Award	Director	AAward	+4,000 sh	—	—	71,439
2009-01-02	PENWEST PHARMACEUTICALS COA Award	Director	AAward	+4,192 sh	—	—	61,439
2009-01-02	PENWEST PHARMACEUTICALS COA Award	Director	AAward	+6,000 sh	—	—	67,439
2008-01-02	PENWEST PHARMACEUTICALS COA Award	Director	AAward	+6,000 sh	—	—	44,576
2008-01-02	PENWEST PHARMACEUTICALS COA Award	Director	AAward	+1,294 sh	—	—	38,576
2007-10-01	PENWEST PHARMACEUTICALS COA Award	Director	AAward	+628 sh	—	—	37,282
2007-07-02	PENWEST PHARMACEUTICALS COA Award	Director	AAward	+558 sh	—	—	36,654
2007-02-06	RespireRx Pharmaceuticals Inc.Options to Purchase Common StockA Award	Director	AAward	+25K sh	—	—	25,000
2006-10-02	PENWEST PHARMACEUTICALS COA Award	Director	AAward	+424 sh	—	—	28,976
2006-07-03	PENWEST PHARMACEUTICALS COA Award	Director	AAward	+324 sh	—	—	28,552
2006-01-03	PENWEST PHARMACEUTICALS COA Award	Director	AAward	+361 sh	—	—	27,905
2006-01-03	PENWEST PHARMACEUTICALS COA Award	Director	AAward	+6,000 sh	—	—	27,544
2005-10-03	PENWEST PHARMACEUTICALS COA Award	Director	AAward	+403 sh	—	—	21,544
2005-07-01	PENWEST PHARMACEUTICALS COA Award	Director	AAward	+604 sh	—	—	21,141
2004-12-16	RespireRx Pharmaceuticals Inc.Options to purchase common stockA Award	Director	AAward	+25K sh	—	—	25,000
2003-10-31	RespireRx Pharmaceuticals Inc.Options to Purchase Common StockA Award	Director	AAward	+30K sh	—	—	30,000

Recent filings

Accepted (ET)
May 134
DRAKE PETER F0000899243-19-013263
SEC(opens sec.gov)
Jul 214
NAVIDEA BIOPHARMACEUTICALS, INC.0001144204-15-043411
SEC(opens sec.gov)
Mar 304
NAVIDEA BIOPHARMACEUTICALS, INC.0001144204-15-019364
SEC(opens sec.gov)
Feb 94
NAVIDEA BIOPHARMACEUTICALS, INC.0001144204-15-006981
SEC(opens sec.gov)
Nov 124
NAVIDEA BIOPHARMACEUTICALS, INC.0001144204-14-066987
SEC(opens sec.gov)
Feb 184
NAVIDEA BIOPHARMACEUTICALS, INC.0001225208-14-004932
SEC(opens sec.gov)
Feb 264
DRAKE PETER F0001225208-13-005552
SEC(opens sec.gov)
Aug 74
DRAKE PETER F0001181431-12-044063
SEC(opens sec.gov)
Apr 114
DRAKE PETER F0001225208-12-009631
SEC(opens sec.gov)
Oct 184
DRAKE PETER F0001225208-11-023478
SEC(opens sec.gov)
May 64
DRAKE PETER F0000930413-11-003754
SEC(opens sec.gov)
Mar 34
DRAKE PETER F0001181431-11-015237
SEC(opens sec.gov)
Sep 224
DRAKE PETER F0001209191-10-047265
SEC(opens sec.gov)
Apr 54
DRAKE PETER F0001209191-10-020674
SEC(opens sec.gov)
Mar 44
DRAKE PETER F0001181431-10-014046
SEC(opens sec.gov)
Feb 224
DRAKE PETER F0001209191-10-011034
SEC(opens sec.gov)
Jan 54
DRAKE PETER F0001209191-10-000938
SEC(opens sec.gov)

Companies

Address

39 OLD RIDGEBURY ROAD SUITE 11

DANBURY, CT, 06810-5120